Search Results 1-10 of 12671 for ���������������������������op������r���:za33���

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Displaying 1-5 out of 5 doctors available. Last Name Initial: R ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Displaying 1-6 out of 6 doctors available. Last Name Initial: R ...

  3. Movement disorders - Doctors and departments - Mayo Clinic

    There are no doctors whose last name begins with the letter R R; Find a ... r spinal cord injury, Inpatient rehabilitation , Outpatient clinical ...

  4. Transoral robotic surgery - Doctors & Departments - Mayo Clinic

    Displaying 1-1 out of 1 doctors available. Last Name Initial: J. Jeffrey R. Janus, M.D.. Otolaryngologist. Jacksonville, FL. Areas of ...

  5. Robotic surgery - Doctors & Departments - Mayo Clinic

    Trenton R. Foster, M.D.. Endocrine Surgeon. Rochester, MN ...

  6. AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL - Mayo Clinic

    AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...

  7. Ranolazine (oral route) - Mayo Clinic

    Ranolazine is used to treat chronic angina (chest pain). This medicine is usually used together with other medicines (eg, ACE inhibitors, angiotensin receptor ...

  8. Transcatheter aortic valve replacement (TAVR) - Mayo Clinic

    Nimmagadda R. Allscripts EPSi. Mayo Clinic. Jan. 17, 2025. Makkar RR, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. New ...

  9. Whipple procedure - Doctors & Departments - Mayo Clinic

    International Journal of Surgery. 2022; doi:10.1016/j.ijsu. 2022.106633 . Simon R. Complications after pancreaticoduodenectomy. Surgical Clinics of North ...

  10. Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ - Mayo Clinic

    The purpose of this study is to enroll approximately 235 treatment-naïve subjects with high-risk Diffuse Large B-Cell Lymphoma (DLBCL). Subjects will be ...